Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain

PURPOSE: Cardiovascular and metabolic adverse events are costly to treat, and their incidence is increased amongst people with schizophrenia, with different rates observed for second-generation antipsychotics. To inform treatment choice, this study sought to estimate the lifetime costs associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearns, Benjamin, Cooper, Katy, Cantrell, Anna, Thomas, Chloe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829121/
https://www.ncbi.nlm.nih.gov/pubmed/33505160
http://dx.doi.org/10.2147/NDT.S282856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829121/
https://www.ncbi.nlm.nih.gov/pubmed/33505160
http://dx.doi.org/10.2147/NDT.S282856

Ejemplares similares